{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:31:37Z","timestamp":1790695897518,"version":"4.1.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008247","name":"University of Otago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.pathol.2018.11.003","type":"journal-article","created":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T13:46:48Z","timestamp":1545918408000},"page":"155-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Lipoprotein(a) catabolism: a case of multiple receptors"],"prefix":"10.1016","volume":"51","author":[{"given":"Sally P.A.","family":"McCormick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9162-1640","authenticated-orcid":false,"given":"Wolfgang J.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2018.11.003_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1699-0463.1963.tb01808.x","article-title":"A\u00a0new serum type system in man\u2013the Lp system","volume":"59","author":"Berg","year":"1963","journal-title":"Acta Pathol Microbiol Scand"},{"key":"10.1016\/j.pathol.2018.11.003_bib2","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2018.11.003_bib3","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.pathol.2018.11.003_bib4","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pathol.2018.11.003_bib5","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1161\/ATVBAHA.116.308011","article-title":"Prevalence of elevated Lp(a) mass levels and patient thresholds in 532 359 patients in the United States","volume":"36","author":"Varvel","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pathol.2018.11.003_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCULATIONAHA.107.715698","article-title":"Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study","volume":"117","author":"Kamstrup","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pathol.2018.11.003_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.pathol.2018.11.003_bib8","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1161\/STROKEAHA.106.480657","article-title":"Lipoprotein (a) and stroke: a meta-analysis of observational studies","volume":"38","author":"Smolders","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.pathol.2018.11.003_bib9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCGENETICS.113.000400","article-title":"Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohort","volume":"7","author":"Arsenault","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.pathol.2018.11.003_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2018.11.003_bib11","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1194\/jlr.R071233","article-title":"Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology","volume":"57","author":"Nordestgaard","year":"2016","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/MOL.0000000000000499","article-title":"The journey towards understanding lipoprotein(a) and cardiovascular disease risk: are we there yet?","volume":"29","author":"Boffa","year":"2018","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pathol.2018.11.003_bib13","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/eurheartj\/ehx033","article-title":"Lipoprotein(a): the revenant","volume":"38","author":"Gencer","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pathol.2018.11.003_bib14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.pathol.2018.11.003_bib15","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(18)31652-0","article-title":"Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials","volume":"392","author":"Willeit","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.pathol.2018.11.003_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.plipres.2017.09.001","article-title":"The renaissance of lipoprotein(a): brave new world for preventive cardiology?","volume":"68","author":"Ellis","year":"2017","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib17","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jacc.2012.04.038","article-title":"Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies","volume":"60","author":"Tsimikas","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.pathol.2018.11.003_bib18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1194\/jlr.R060582","article-title":"Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?","volume":"57","author":"Boffa","year":"2016","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2018.04.032","article-title":"Is Lp(a) ready for prime time use in the clinic? A pros-and-cons debate","volume":"274","author":"Kostner","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pathol.2018.11.003_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jacbts.2017.02.004","article-title":"Lipoprotein(a) associated molecules are prominent components in plasma and valve leaflets in calcific aortic valve stenosis","volume":"2","author":"Torzewski","year":"2017","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.pathol.2018.11.003_bib21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.116.020838","article-title":"Oxidized phospholipids on lipoprotein(a) elicit arterial wall inflammation and an inflammatory monocyte response in humans","volume":"134","author":"van der Valk","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.pathol.2018.11.003_bib22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jacbts.2017.03.015","article-title":"Lipoprotein(a) induces human aortic valve interstitial cell calcification","volume":"2","author":"Yu","year":"2017","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.pathol.2018.11.003_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2017.11.014","article-title":"NHLBI working group recommendations to reduce lipoprotein(a)\u2013mediated risk of cardiovascular disease and aortic stenosis","volume":"71","author":"Tsimikas","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.pathol.2018.11.003_bib24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1194\/jlr.R061648","article-title":"Lipoprotein (a) measurements for clinical application","volume":"57","author":"Marcovina","year":"2016","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib25","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jacl.2018.07.003","article-title":"Relationship of lipoprotein(a) molar concentrations and mass according to lipoprotein(a) thresholds and apolipoprotein(a) isoform size","volume":"12","author":"Tsimikas","year":"2018","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.pathol.2018.11.003_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MOL.0000000000000171","article-title":"'LDL-C'\u00a0= LDL-C\u00a0+ Lp(a)-C: implications of achieved ultra-low LDL-C levels in the proprotein convertase subtilisin\/kexin type 9 era of potent LDL-C lowering","volume":"26","author":"Yeang","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pathol.2018.11.003_bib27","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/eurheartj\/ehx546","article-title":"Depicting new pharmacological strategies for familial hypercholesterolaemia involving lipoprotein (a)","volume":"38","author":"Vuorio","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pathol.2018.11.003_bib28","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1194\/jlr.R053066","article-title":"Current therapies for lowering lipoprotein (a)","volume":"57","author":"van Capelleveen","year":"2016","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.108.786822","article-title":"Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice","volume":"118","author":"Merki","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pathol.2018.11.003_bib30","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(16)31009-1","article-title":"Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials","volume":"388","author":"Viney","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.pathol.2018.11.003_bib31","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.2530631","article-title":"The mysteries of lipoprotein(a)","volume":"246","author":"Utermann","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.pathol.2018.11.003_bib32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/330132a0","article-title":"cDNA sequence of human apolipoprotein(a) is homologous to plasminogen","volume":"330","author":"McLean","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2018.11.003_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/hmg\/2.4.361","article-title":"The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms","volume":"2","author":"van der Hoek","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pathol.2018.11.003_bib34","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1172\/JCI115248","article-title":"Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis","volume":"87","author":"Lackner","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2018.11.003_bib35","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1016\/S0021-9258(18)83643-2","article-title":"Rhesus monkey apolipoprotein(a). Sequence, evolution, and sites of synthesis","volume":"264","author":"Tomlinson","year":"1989","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib36","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1021\/bi973186w","article-title":"Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100","volume":"37","author":"Gabel","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.pathol.2018.11.003_bib37","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1074\/jbc.M309414200","article-title":"Quantitative evaluation of the contribution of weak lysine-binding sites present within apolipoprotein(a) kringle IV types 6-8 to lipoprotein(a) assembly","volume":"279","author":"Becker","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib38","doi-asserted-by":"crossref","first-page":"36155","DOI":"10.1074\/jbc.M104789200","article-title":"Identification of a critical lysine residue in apolipoprotein B-100 that mediates noncovalent interaction with apolipoprotein(a)","volume":"276","author":"Becker","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1194\/jlr.M300071-JLR200","article-title":"Mutation of lysine residues in apolipoprotein B-100 causes defective lipoprotein[a] formation","volume":"45","author":"Liu","year":"2004","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib40","doi-asserted-by":"crossref","first-page":"19819","DOI":"10.1016\/S0021-9258(19)36587-1","article-title":"Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100","volume":"268","author":"Koschinsky","year":"1993","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib41","doi-asserted-by":"crossref","first-page":"10147","DOI":"10.1073\/pnas.92.22.10147","article-title":"Mutagenesis of the human apolipoprotein B gene in a yeast artificial chromosome reveals the site of attachment for apolipoprotein(a)","volume":"92","author":"McCormick","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2018.11.003_bib42","doi-asserted-by":"crossref","first-page":"23914","DOI":"10.1074\/jbc.270.41.23914","article-title":"Site-specific mutagenesis demonstrates that cysteine 4326 of apolipoprotein B is required for covalent linkage with apolipoprotein (a) in\u00a0vivo","volume":"270","author":"Callow","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib43","doi-asserted-by":"crossref","first-page":"24369","DOI":"10.1016\/S0021-9258(18)35775-2","article-title":"Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a)","volume":"267","author":"Chiesa","year":"1992","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0009-3084(94)90131-7","article-title":"Intracellular processing of apo(a) in primary baboon hepatocytes","volume":"67\u201368","author":"White","year":"1994","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.pathol.2018.11.003_bib45","doi-asserted-by":"crossref","first-page":"28716","DOI":"10.1016\/S0021-9258(19)61964-2","article-title":"Cell surface assembly of lipoprotein(a) in primary cultures of baboon hepatocytes","volume":"269","author":"White","year":"1994","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib46","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1021\/bi972761t","article-title":"Intracellular metabolism of human apolipoprotein(a) in stably transfected Hep G2 cells","volume":"37","author":"Lobentanz","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.pathol.2018.11.003_bib47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0021-9150(00)00732-2","article-title":"The metabolism of lipoprotein(a) and other apolipoprotein B-containing lipoproteins: a kinetic study in humans","volume":"157","author":"Demant","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pathol.2018.11.003_bib48","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1074\/jbc.272.9.5659","article-title":"Expression of a recombinant apolipoprotein(a) in HepG2 cells. Evidence for intracellular assembly of lipoprotein(a)","volume":"272","author":"Bonen","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0009-3084(94)90132-5","article-title":"Oleate stimulates the formation of triglyceride-rich particles containing apoB100-apo(a) in long-term primary cultures of human hepatocytes","volume":"67\u201368","author":"Edelstein","year":"1994","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.pathol.2018.11.003_bib50","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.atherosclerosis.2012.09.031","article-title":"In\u00a0vivo stable-isotope kinetic study suggests intracellular assembly of lipoprotein(a)","volume":"225","author":"Frischmann","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pathol.2018.11.003_bib51","first-page":"3267","article-title":"Metabolism of Apo(a) and ApoB100 of lipoprotein(a) in women: effect of postmenopausal estrogen replacement","volume":"83","author":"Su","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2018.11.003_bib52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0021-9150(91)90244-W","article-title":"Plasma lipoprotein distribution of apolipoprotein(a) in the fed and fasted states","volume":"90","author":"Cohn","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pathol.2018.11.003_bib53","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/S0022-2275(20)31535-2","article-title":"Isolation, quantitation, and characterization of a stable complex formed by Lp[a] binding to triglyceride-rich lipoproteins","volume":"42","author":"Gaubatz","year":"2001","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib54","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.metabol.2015.10.031","article-title":"Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a)","volume":"65","author":"Diffenderfer","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.pathol.2018.11.003_bib55","doi-asserted-by":"crossref","first-page":"13213","DOI":"10.1021\/ja203679g","article-title":"Softness of atherogenic lipoproteins: a comparison of very low density lipoprotein (VLDL) and low density lipoprotein (LDL) using elastic incoherent neutron scattering (EINS)","volume":"133","author":"Mikl","year":"2011","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.pathol.2018.11.003_bib56","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/01.ATV.20.5.1301","article-title":"Well-defined regions of apolipoprotein B-100 undergo conformational change during its intravascular metabolism","volume":"20","author":"Wang","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pathol.2018.11.003_bib57","doi-asserted-by":"crossref","first-page":"9919","DOI":"10.1021\/bi060283t","article-title":"Catalysis of covalent Lp(a) assembly: evidence for an extracellular enzyme activity that enhances disulfide bond formation","volume":"45","author":"Becker","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.pathol.2018.11.003_bib58","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.metabol.2004.10.001","article-title":"The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings","volume":"54","author":"Jenner","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.pathol.2018.11.003_bib59","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.jprot.2011.07.008","article-title":"Proteomics of Lipoprotein(a) identifies a protein complement associated with response to wounding","volume":"74","author":"von Zychlinski","year":"2011","journal-title":"J\u00a0Proteomics"},{"key":"10.1016\/j.pathol.2018.11.003_bib60","doi-asserted-by":"crossref","first-page":"31151","DOI":"10.1074\/jbc.270.52.31151","article-title":"Enhanced association of platelet-activating factor acetylhydrolase with lipoprotein (a) in comparison with low density lipoprotein","volume":"270","author":"Blencowe","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib61","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.115.016757","article-title":"Autotaxin derived from lipoprotein(a) and valve interstitial cells promotes inflammation and mineralization of the aortic valve","volume":"132","author":"Bouchareb","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.pathol.2018.11.003_bib62","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1194\/jlr.M800174-JLR200","article-title":"A\u00a0novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma","volume":"49","author":"Bergmark","year":"2008","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib63","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/joim.12519","article-title":"Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease","volume":"280","author":"Nsaibia","year":"2016","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.pathol.2018.11.003_bib64","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/S0021-9258(18)34975-5","article-title":"Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight","volume":"257","author":"Schneider","year":"1982","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib65","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","article-title":"A\u00a0receptor-mediated pathway for cholesterol homeostasis","volume":"232","author":"Brown","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.pathol.2018.11.003_bib66","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1194\/jlr.M500249-JLR200","article-title":"Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a]","volume":"46","author":"Cain","year":"2005","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib67","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1042\/bj20030932","article-title":"Galactose-specific asialoglycoprotein receptor is involved in lipoprotein (a) catabolism","volume":"376","author":"Hrzenjak","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.pathol.2018.11.003_bib68","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-5793(81)81153-2","article-title":"Binding of LP(a) to the low density lipoprotein receptor of human fibroblasts","volume":"132","author":"Havekes","year":"1981","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pathol.2018.11.003_bib69","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0006-291X(81)80179-9","article-title":"Uptake of Lp (a) lipoprotein by cultured fibroblasts","volume":"102","author":"Floren","year":"1981","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pathol.2018.11.003_bib70","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1172\/JCI110896","article-title":"Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man","volume":"71","author":"Krempler","year":"1983","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2018.11.003_bib71","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-2275(20)37595-7","article-title":"Interaction of a recombinant form of apolipoprotein[a] with human fibroblasts and with the human hepatoma cell line HepG2","volume":"37","author":"Tam","year":"1996","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib72","doi-asserted-by":"crossref","first-page":"11649","DOI":"10.1074\/jbc.M114.611988","article-title":"Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin\/kexin type 9 through the low density lipoprotein receptor","volume":"290","author":"Romagnuolo","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib73","doi-asserted-by":"crossref","first-page":"e0180869","DOI":"10.1371\/journal.pone.0180869","article-title":"Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin\/kexin type 9","volume":"12","author":"Romagnuolo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2018.11.003_bib74","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI114602","article-title":"Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice","volume":"85","author":"Hofmann","year":"1990","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2018.11.003_bib75","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.ejhg.5200152","article-title":"Concentrations of the atherogenic Lp(a) are elevated in FH","volume":"6","author":"Lingenhel","year":"1998","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.pathol.2018.11.003_bib76","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.pathol.2018.11.003_bib77","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0022-2275(20)37140-6","article-title":"Cellular uptake of lipoprotein[a] by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor-related protein","volume":"38","author":"Reblin","year":"1997","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib78","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1172\/JCI117794","article-title":"The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans","volume":"95","author":"Rader","year":"1995","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2018.11.003_bib79","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0021-9150(91)90025-X","article-title":"Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjects","volume":"87","author":"Knight","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pathol.2018.11.003_bib80","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0009-3084(94)90142-2","article-title":"Lp(a) catabolism in hypercholesterolaemic individuals","volume":"67\u201368","author":"Knight","year":"1994","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.pathol.2018.11.003_bib81","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.ATV.16.1.129","article-title":"Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect","volume":"16","author":"Carmena","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pathol.2018.11.003_bib82","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.pathol.2018.11.003_bib83","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.113.004406","article-title":"Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER trial (justification for the use of statins in prevention: an Intervention trial evaluating Rosuvastatin)","volume":"129","author":"Khera","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.pathol.2018.11.003_bib84","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jacl.2016.01.005","article-title":"Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a)","volume":"10","author":"Yeang","year":"2016","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.pathol.2018.11.003_bib85","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/CIRCULATIONAHA.113.001969","volume":"128","author":"Desai","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.pathol.2018.11.003_bib86","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.amjcard.2014.05.060","article-title":"Effect of alirocumab, a monoclonal proprotein convertase subtilisin\/kexin 9 antibody, on lipoprotein(a) concentrations (a pooled analysis of 150 mg every two weeks dosing from phase 2 trials)","volume":"114","author":"Gaudet","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pathol.2018.11.003_bib87","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2014.01.006","article-title":"Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials","volume":"63","author":"Raal","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.pathol.2018.11.003_bib88","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jacbts.2016.06.006","article-title":"PCSK9 modulates the secretion but not the cellular uptake of lipoprotein(a) ex\u00a0vivo: an effect blunted by alirocumab","volume":"1","author":"Villard","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.pathol.2018.11.003_bib89","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1042\/CS20180040","article-title":"PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate","volume":"132","author":"Croyal","year":"2018","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pathol.2018.11.003_bib90","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1093\/eurheartj\/ehy122","article-title":"Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics","volume":"39","author":"Watts","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pathol.2018.11.003_bib91","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.116.025253","article-title":"Effects of PCSK9 inhibition with alirocumab on lipoprotein metabolism in healthy humans","volume":"135","author":"Reyes-Soffer","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.pathol.2018.11.003_bib92","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1172\/JCI119753","article-title":"The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor","volume":"100","author":"Argraves","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2018.11.003_bib93","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1043-2760(01)00526-4","article-title":"Diverse roles for the LDL receptor family","volume":"13","author":"Strickland","year":"2002","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.pathol.2018.11.003_bib94","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1074\/jbc.M113.529271","article-title":"Clusterin is a ligand for apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and signals via the Reelin-signaling pathway","volume":"289","author":"Leeb","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib95","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1074\/jbc.M109.025973","article-title":"Differential functions of ApoER2 and very low density lipoprotein receptor in Reelin signaling depend on differential sorting of the receptors","volume":"285","author":"Duit","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib96","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/341162a0","article-title":"The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein","volume":"341","author":"Beisiegel","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2018.11.003_bib97","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1172\/JCI1240","article-title":"Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants","volume":"101","author":"Rohlmann","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2018.11.003_bib98","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-5793(93)81087-G","article-title":"Heterogeneous lipoprotein (a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor-related protein\/alpha 2-macroglobulin receptor","volume":"325","author":"Marz","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pathol.2018.11.003_bib99","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jprot.2014.04.030","article-title":"Absolute quantification of apolipoproteins and associated proteins on human plasma lipoproteins","volume":"106","author":"von Zychlinski","year":"2014","journal-title":"J\u00a0Proteomics"},{"key":"10.1016\/j.pathol.2018.11.003_bib100","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.ki.5002240","article-title":"Evidence mounts for a role of the kidney in lipoprotein(a) catabolism","volume":"71","author":"Albers","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.pathol.2018.11.003_bib101","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.ATV.19.3.552","article-title":"Identification of megalin\/gp330 as a receptor for lipoprotein(a) in\u00a0vitro","volume":"19","author":"Niemeier","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pathol.2018.11.003_bib102","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1074\/jbc.M708098200","article-title":"The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2","volume":"283","author":"Poirier","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib103","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/CIRCRESAHA.116.308811","article-title":"PCSK9 association with lipoprotein(a)","volume":"119","author":"Tavori","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib104","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2018.11.003_bib105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.pathol.2018.11.003_bib106","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.molimm.2014.05.008","article-title":"Toll-like receptor co-receptors as master regulators of the immune response","volume":"63","author":"Di Gioia","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.pathol.2018.11.003_bib107","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.09.010","article-title":"Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress","volume":"12","author":"Seimon","year":"2010","journal-title":"Cell Metabol"},{"key":"10.1016\/j.pathol.2018.11.003_bib108","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1194\/jlr.M076232","article-title":"A\u00a0genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms","volume":"58","author":"Mack","year":"2017","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib109","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bbrc.2008.07.023","article-title":"Inflammation stimulates the expression of PCSK9","volume":"374","author":"Feingold","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pathol.2018.11.003_bib110","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1194\/jlr.M060210","article-title":"Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)","volume":"56","author":"Scipione","year":"2015","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib111","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.271.5248.518","article-title":"Identification of scavenger receptor SR-BI as a high density lipoprotein receptor","volume":"271","author":"Acton","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pathol.2018.11.003_bib112","doi-asserted-by":"crossref","first-page":"32920","DOI":"10.1074\/jbc.273.49.32920","article-title":"Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice","volume":"273","author":"Wang","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib113","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.atherosclerosis.2018.06.881","article-title":"Endocytosis of lipoproteins","volume":"275","author":"Zanoni","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pathol.2018.11.003_bib114","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1194\/jlr.M038877","article-title":"Scavenger receptor-BI is a receptor for lipoprotein(a)","volume":"54","author":"Yang","year":"2013","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib115","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1194\/jlr.M056150","article-title":"Lipoprotein (a) upregulates ABCA1 in liver cells via scavenger receptor-B1 through its oxidized phospholipids","volume":"56","author":"Sharma","year":"2015","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib116","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/CIRCGENETICS.116.001402","article-title":"SCARB1 gene variants are associated with the phenotype of combined high high-density lipoprotein cholesterol and high lipoprotein (a)","volume":"9","author":"Yang","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.pathol.2018.11.003_bib117","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MOL.0000000000000395","article-title":"Asialoglycoprotein receptors as important mediators of plasma lipids and atherosclerosis","volume":"28","author":"Igdoura","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pathol.2018.11.003_bib118","doi-asserted-by":"crossref","first-page":"22200","DOI":"10.1074\/jbc.M102150200","article-title":"Structural elucidation of the N- and O-glycans of human apolipoprotein(a): role of o-glycans in conferring protease resistance","volume":"276","author":"Garner","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib119","doi-asserted-by":"crossref","DOI":"10.1093\/glycob\/cwl025","article-title":"Galectin-1: a small protein with major functions","volume":"16","author":"Camby","year":"2006","journal-title":"Glycobiology"},{"key":"10.1016\/j.pathol.2018.11.003_bib120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.yexmp.2007.04.004","article-title":"Galectin-1, an endogenous lectin produced by arterial cells, binds lipoprotein(a) [Lp(a)] in situ: relevance to atherogenesis","volume":"83","author":"Chellan","year":"2007","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.pathol.2018.11.003_bib121","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s11745-014-3941-4","article-title":"Circulating Lp(a):LDL complexes contain LDL molecules proportionate to Lp(a) size and bind to galectin-1: a possible route for LDL entry into cells","volume":"49","author":"Kalaivani","year":"2014","journal-title":"Lipids"},{"key":"10.1016\/j.pathol.2018.11.003_bib122","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1161\/01.ATV.17.10.2036","article-title":"Lipoprotein(a) isoforms display differences in affinity for plasminogen-like binding to human mononuclear cells","volume":"17","author":"Kang","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pathol.2018.11.003_bib123","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/339301a0","article-title":"A\u00a0potential basis for the thrombotic risks associated with lipoprotein(a)","volume":"339","author":"Miles","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2018.11.003_bib124","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/s-0038-1653797","article-title":"Interaction of Lp(a) with plasminogen binding sites on cells","volume":"73","author":"Miles","year":"1995","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.pathol.2018.11.003_bib125","doi-asserted-by":"crossref","first-page":"21962","DOI":"10.1016\/S0021-9258(18)54731-1","article-title":"The endothelial cell tissue plasminogen activator receptor. Specific interaction with plasminogen","volume":"266","author":"Hajjar","year":"1991","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib126","first-page":"141806","article-title":"So many plasminogen receptors: why?","volume":"2012","author":"Plow","year":"2012","journal-title":"J\u00a0Biomed Biotechnol"},{"key":"10.1016\/j.pathol.2018.11.003_bib127","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.116.310272","article-title":"Recycling of apolipoprotein(a) after PlgRKT-mediated endocytosis of lipoprotein(a)","volume":"120","author":"Sharma","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib128","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/blood-2008-11-188938","article-title":"Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation","volume":"115","author":"Andronicos","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2018.11.003_bib129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/jth.13532","article-title":"Deficiency of plasminogen receptor, Plg-RKT , causes defects in plasminogen binding and inflammatory macrophage recruitment in\u00a0vivo","volume":"15","author":"Miles","year":"2017","journal-title":"J\u00a0Thromb Haemostasis"},{"key":"10.1016\/j.pathol.2018.11.003_bib130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vph.2011.03.003","article-title":"The annexin A2 system and vascular homeostasis","volume":"54","author":"Flood","year":"2011","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.pathol.2018.11.003_bib131","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1050-1738(99)00020-1","article-title":"Annexin II: a mediator of the plasmin\/plasminogen activator system","volume":"9","author":"Hajjar","year":"1999","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.pathol.2018.11.003_bib132","doi-asserted-by":"crossref","first-page":"31791","DOI":"10.1074\/jbc.M805971200","article-title":"Annexin A2 is a C-terminal PCSK9-binding protein that regulates endogenous low density lipoprotein receptor levels","volume":"283","author":"Mayer","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2018.11.003_bib133","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-2275(20)33367-8","article-title":"Presecretory degradation of apolipoprotein [a] is mediated by the proteasome pathway","volume":"40","author":"White","year":"1999","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib134","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-2275(20)40742-4","article-title":"Intracellular maturation of apolipoprotein[a] and assembly of lipoprotein[a] in primary baboon hepatocytes","volume":"34","author":"White","year":"1993","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pathol.2018.11.003_bib135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1050-1738(00)00033-5","article-title":"The cell biology and physiologic relevance of ApoE recycling","volume":"10","author":"Fazio","year":"2000","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.pathol.2018.11.003_bib136","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.ATV.16.8.905","article-title":"Urinary excretion of apo(a) fragments. Role in apo(a) catabolism","volume":"16","author":"Kostner","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pathol.2018.11.003_bib137","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2018.11.003_bib138","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/ATVBAHA.116.308704","article-title":"Lipoprotein(a) mass levels increase significantly according to APOE genotype: an analysis of 431 239 patients","volume":"37","author":"Moriarty","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pathol.2018.11.003_bib139","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jama.298.11.1300","article-title":"Association of apolipoprotein E genotypes with lipid levels and coronary risk","volume":"298","author":"Bennet","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.pathol.2018.11.003_bib140","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1194\/jlr.R077693","article-title":"The metabolism of lipoprotein (a): an ever-evolving story","volume":"58","author":"Reyes-Soffer","year":"2017","journal-title":"J\u00a0Lipid Res"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302518305269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302518305269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T15:03:16Z","timestamp":1617634996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302518305269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":140,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0031302518305269"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2018.11.003","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein(a) catabolism: a case of multiple receptors","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2018.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}